69 - Changing the Vaccine Narrative: Building Confidence Across the Lifespan

Thursday, October 17, 2024

1:45 PM – 3:00 PM US PT

Location: Petree D

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

C. Mary Healy, MD, FIDSA (she/her/hers)

Associate Professor of Pediatrics, Infectious Diseases
Baylor College of Medicine
Houston, TX, United States
KE

Kathryn Edwards, MD

Professor of Pediatrics Emerita
Vanderbilt University Medical Center
Nashville, TN, United States

Faculty(s)

Laura Riley, MD (she/her/hers)

Chair Ob/Gyn
WEILL CORNELL MEDICINE
New York, NY, United States
Robert Hopkins, Jr., MD (he/him/his)

Medical Director
National Foundation for Infectious Diseases
Little Rock, AR, United States
Dorit Reiss, PHD, LLB (she/her/hers)

Professor of Law
UC Law San Francisco
San Francisco, CA, United States

Disclosure(s):

C. Mary Healy, MD, FIDSA: Dexcom Inc: Stocks/Bonds (Public Company); Hillevax, Inc: Member of Advisory board; Intuitive Surgical Inc: Stocks/Bonds (Public Company); Quidel Corporation: Stocks/Bonds (Public Company); Vapotherm: Stocks/Bonds (Public Company)

Kathryn M. Edwards, MD: Bionet: Advisor/Consultant (Terminated); CSL Seqirus: Data Monitoring Committee (Ongoing); Dynavax: Advisor/Consultant (Ongoing); F. Hoffmann-La Roche Ltd.: Data Monitoring Committee (Ongoing); GlaxoSmithKline Biologicals: Advisor/Consultant (Ongoing); Merck and Company, Inc.: Data Monitoring Committee (Ongoing); Moderna, Inc.: Data Monitoring Committee (Ongoing); Novartis International AG: Data Monitoring Committee (Ongoing); Pfizer, Inc.: Data Monitoring Committee (Ongoing); Sanofi Pasteur LLC: Data Monitoring Committee (Ongoing); X-4 Pharma: Adjudication Committee (Ongoing)

Laura Riley, MD: Brigham and Women's Hospital: Grant/Research Support (Ongoing); contemporary obgyn: Board Member (Ongoing); Medscape: Advisor/Consultant (Terminated); Moderna Therapeutics: Advisor/Consultant (Ongoing); New England Journal of Medicine: Board Member (Ongoing); Pfizer, Inc.: Advisor/Consultant (Terminated); Up To Date Contributor: Honoraria (Ongoing)

Robert H. Hopkins, MD, Jr.: No financial relationships to disclose

Dorit Reiss, PHD, LLB: The GSK group of companies: Stocks/Bonds (Public Company) (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

analyze recommendations for vaccination during pregnancy and describe strategies to improve updake;
recognize the impact of vaccine hesitancy on personal and societal health across the lifespan;
describe interventions to promote vaccine confidence across the lifespan;
describe the intersection between vaccines and the law.

Presentations:

1:45 PM – 2:10 PM US PT

Vaccine confidence:It’s not just for kids!
Speaker: Robert H. Hopkins, Jr., MD (he/him/his) – National Foundation for Infectious Diseases
2:10 PM – 2:35 PM US PT

Pregnant or Breastfeeding: Vaccines?
Speaker: Laura Riley, MD (she/her/hers) – WEILL CORNELL MEDICINE
2:35 PM – 3:00 PM US PT

Vaccines Law: Misinformation, and Experts
Speaker: Dorit Reiss, PHD, LLB (she/her/hers) – UC Law San Francisco